Upgrade to SI Premium - Free Trial

Bayer AG (BAYRY)

12.07 -0.19 (1.55%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting October 8, 2026 3:00 PM - BizWire Actress and Menopause Advocate Melissa Joan Hart Partners with Bayer to Raise Awareness about Lynkuet® (elinzanetant), a Prescription Treatment for Moderate to Severe Hot Flashes due to Menopause October 8, 2026 8:30 AM - BizWire FDA accepts Bayer's application to expand Kerendia to CKD without diabetes October 8, 2026 2:30 AM - StreetInsider U.S. FDA Accepts Bayer’s Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes October 8, 2026 2:30 AM - BizWire Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States October 2, 2026 3:10 PM - BizWire Alka-Seltzer Plus® to Relaunch as Alka-Seltzer™ Cold in 2026, Bringing Simpler Shopping and More Value to the Cough/Cold Aisle October 1, 2026 9:01 AM - BizWire MiraSOFT™ Launch at CVS Pharmacy, Expanding the MIRA Portfolio with a Stool Softener Option September 29, 2026 9:01 AM - BizWire FDA grants priority review to Bayer's Lynkuet for breast cancer use September 28, 2026 8:00 AM - StreetInsider U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related September 28, 2026 8:00 AM - BizWire Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs September 17, 2026 9:05 AM - BizWire FDA clears Bayer's Kerendia for kidney disease in type 1 diabetes September 17, 2026 2:30 AM - StreetInsider Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes September 17, 2026 2:30 AM - BizWire Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road September 10, 2026 3:54 PM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR65 at HSBC September 10, 2026 3:28 AM - StreetInsider FDA grants Bayer's HYRNUO accelerated approval as first-line NSCLC therapy September 9, 2026 10:22 PM - StreetInsider U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer September 9, 2026 10:21 PM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR70 at Barclays September 8, 2026 5:38 AM - StreetInsider BofA Securities Reiterates Buy Rating on Bayer AG (BAYN:GR) (BAYRY) September 4, 2026 6:06 AM - StreetInsider Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026 August 30, 2026 7:45 AM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR59 at Kepler Cheuvreux August 26, 2026 4:49 AM - StreetInsider Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026 August 20, 2026 8:00 AM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR53.50 at Berenberg August 18, 2026 5:05 AM - StreetInsider LYNKUET® (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer August 17, 2026 2:21 PM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR61 at JPMorgan August 6, 2026 4:37 AM - StreetInsider One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin July 28, 2026 8:00 AM - BizWire New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters July 23, 2026 1:03 PM - BizWire Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials July 17, 2026 8:30 AM - BizWire Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming July 14, 2026 8:10 AM - BizWire Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays July 14, 2026 4:51 AM - StreetInsider Full Article List